An international, Phase III clinical trial led by investigators at Mass General Brigham could improve the treatment of a rare ...

For unresectable or metastatic liver cancer, the TPST-1120-301 trial of amezalpat combination therapy has received a “Study ...

Sensei Biotherapeutics is laying off 46% of its workforce as the cancer-focused biotech looks to preserve cash to take its ...

Longboard Pharmaceuticals has commenced the Phase III DEEp OCEAN Study of its investigational oral drug bexicaserin for ...

Compass Pathways' latest update reveals extended trial timelines, staff cuts, and financial concerns, raising questions about ...

A first healthy adults group has been dosed in an early clinical trial of an oral and myelin-protective treatment for all ...

The largest ever clinical trial of T cell therapy for solid tumors has ended, heralding a new era for precision T cell ...

The Phase I Trial data will be submitted to regulatory agencies for review for advancing the vaccine into a Phase II efficacy ...

Flourish’s network of 24 sites and 150 investigators conducts studies spanning all phases of clinical trial research Founded in 2010, NMS Capital invests in the lower middle market NMS Capital ...

The FDA recently approved a phase 2 clinical trial to investigate the efficacy of leronlimab in patients with relapsed or ...